Publications are the primary method for reporting and long-term documentation of the research conducted at the NIPER-Hyderabad. Here the list of publications published in year wise...

1. Kabra, P.; Sakla, A. P.; Kumar, M.; Sathish, M.; Laxmikeshav, K.; Dandekar, M. P.; Shankaraiah, N. Regiospecific Synthesis of Thioether-Linked 3-Hydroxyoxindoles from Spiro-Epoxy Oxindoles as Cytotoxic and Tubulin Polymerization Inhibitors. ChemistrySelect 2024, 9, e202404458. https://doi.org/10.1002/slct.202404458
2. Kumawat, A.; Mansuri, S.; Galla, M. S.; Shankaraiah, N. KSCN-Mediated One-Pot Thiocyanation Tandem Cyclization of Enaminones: A Facile Access to 2-Amino/Imino Thiazolo Fused Chromone and Coumarin Frameworks. European Journal of Organic Chemistry 2024, 27, e202400690. https://doi.org/10.1002/ejoc.202400690
3. Khan, M. A.; Reddyrajula, R.; Sakla, A. P.; Sathish, M.; Shankaraiah, N. Microwave-Assisted One-Pot Synthesis of Tetrahydro-β-Carbolines by Fe(II)-Catalyst: Utilizing Methanol as Methylene Synthon. Asian Journal of Organic Chemistry 2024, 13, e202400404. https://doi.org/10.1002/ajoc.202400404
4. Valapil, D. G.; Devabattula, G.; Sakla, A. P.; Godugu, C.; Shankaraiah, N. Design, Development of Pyrazole-Linked Spirocyclopropyloxindole-Carboxamides as Potential Cytotoxic Agents and Selective Type III Allosteric VEGFR-2 Inhibitors. ChemMedChem 2024, 19, e202400422. https://doi.org/10.1002/cmdc.202400422
5. Khan, M. A.; Sharma, A.; Bora, D.; Sindhuja, R. H.; Phanindranath, R.; Nagesh, N.; Shankaraiah, N. Development of β-Carboline-Coumarin Based Hybrids as Potential Cytotoxic and Topoisomerase IIα Inhibitors. ChemistrySelect 2024, 9, e202401682. https://doi.org/10.1002/slct.202401682
6. Madhurya, M. S.; Thakur, V.; Dastari, S.; Shankaraiah, N. Pyrrolo[2,3-d]pyrimidines as Potential Kinase Inhibitors in Cancer Drug Discovery: A Critical Review. Bioorganic Chemistry 2024, 153, 107867. https://doi.org/10.1016/j.bioorg.2024.107867
7. Galla, M. S.; Kale, N.; Sharma, A.; Hajre, A.; Godugu, C.; Shankaraiah, N. Development of Chromone-Thiazolidine-2,4-Dione Knoevenagel Conjugates as Apoptosis Inducing Agents. Bioorganic & Medicinal Chemistry Letters 2024, 109, 129853. https://doi.org/10.1016/j.bmcl.2024.129853
8. Dastari, S.; Murugappan, S.; John, S. E.; Shankaraiah, N. Microwave-Assisted Ru(II)-Catalyzed Regioselective Methyl Acylation of 2-Arylbenzoazoles: Synthesis of Benzofuran Conjugates via C−H Activation/Annulation. Journal of Organic Chemistry 2024, 89, 7027–7035. https://doi.org/10.1021/acs.joc.4c00402
9. Sakla, A. P.; Bazaz, M. R.; Mahale, A.; Sharma, P.; Valapil, D. G.; Kulkarni, O. P.; Dandekar, M. P.; Shankaraiah, N. Development of Benzimidazole-Substituted Spirocyclopropyl Oxindole Derivatives as Cytotoxic Agents: Tubulin Polymerization Inhibition and Apoptosis Inducing Studies. ChemMedChem 2024, 19, e202400052. https://doi.org/10.1002/cmdc.202400052
10. Mishra, P.; Sharma, N.; Galla, M. S.; Shankaraiah, N. Recent Insights of PROTAC Developments in Inflammation-Mediated and Autoimmune Diseases: A Critical Review. RSC Medicinal Chemistry 2024, 15, 2585–2600. https://doi.org/10.1039/d4md00142g
11. Galla, M. S.; Kale, N. B.; Kumawat, A.; Bora, D.; Shankaraiah, N. Rh(III)-Catalysed C–H Annulation of cis-Stilbene Acids with 2-Diazo-1,3-Diketones: Facile Access to 6,7-Dihydrobenzofuran-4(5H)-one and α-Pyrone Scaffolds. Organic & Biomolecular Chemistry 2024, 22, 3933–3939. https://doi.org/10.1039/d4ob00151f
12. Murugappan, S.; Jungare, K.; Dastari, S.; Barve, N. M.; Shankaraiah, N. Hydrazide-Hydrazone/Hydrazone as Enabling Linkers in Anti-Cancer Drug Discovery: A Comprehensive Review. Journal of Molecular Structure 2024, 1307, 138012. https://doi.org/10.1016/j.molstruc.2024.138012
13. Valapil, D. G.; Shankaraiah, N. Spirooxindole Derivatives as Kinase Based Anti-Cancer Agents. In Spirooxindole: Chemistry, Synthesis, Characterization and Biological Significance; Elsevier, 2024; 1st Edition. ISBN: 978-0-443-22324-2. https://doi.org/10.1016/B978-0-443-22324-2.00017-5
14. Golla, V. M.; Kalyan, M.; Gholap, U.; Padhy, H. P.; Ramachandran, R. K.; Samanthula, G. Discerning the stability behaviour of mavacamten availing liquid chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy: In silico toxicity and mutagenicity prediction of degradation products. Journal of Mass Spectrometry 2024, 59 (3), e5007. https://doi.org/10.1002/jms.5007
15. Pilli, P.; Kommalapati, H. S.; Golla, V. M.; Khemchandani, R.; Ramachandran, R. K.; Samanthula, G. Covalent organic frameworks: Spotlight on applications in the pharmaceutical arena. Bioanalysis 2024, 16 (8), 279–305. https://doi.org/10.4155/bio-2023-0256
16. Chaganti, S.; Kushwah, B. S.; Velip, L.; Tiwari, S. S.; Chilvery, S.; Godugu, C.; Samanthula, G. In vivo and in vitro metabolite profiling of nirmatrelvir using LC–Q‐ToF–MS/MS along with the in silico approaches for prediction of metabolites and their toxicity. Biomedical Chromatography 2024, 38 (5), e5849. https://doi.org/10.1002/bmc.5849
17. Golla, V. M.; Khemchandani, R.; Chaganti, S.; Samanthula, G. Separation and characterization of hydrolytic degradation product of deucravacitinib by validated high-performance liquid chromatography method and liquid chromatography-mass spectrometry. Separation Science Plus 2024, 7 (5), 2300180. https://doi.org/10.1002/sscp.202300180
18. Chaganti, S.; Chauhan, U.; Bhatt, N.; Kommalapati, H.; Golla, V. M.; Pilli, P.; Samanthula, G. LC-HRMS and NMR studies for the characterization of degradation impurities of ubrogepant along with the in silico approaches for the prediction of degradation and toxicity. Journal of Pharmaceutical and Biomedical Analysis 2024, 243, 116117. https://doi.org/10.1016/j.jpba.2024.116117
19. Chaganti, S.; Nelapati, C.; Jain, D.; Roshitha, K.; Kanchupalli, V.; Samanthula, G. Separation and characterization of degradation impurities of upadacitinib by liquid chromatography and high resolution mass spectrometry. Journal of Chromatography B 2024, 1247, 124319. https://doi.org/10.1016/j.jchromb.2024.124319
20. Nizam, M. V. P.; Yerram, S.; Patnam, J. D.; A. C. S.; Aglave, G.; Joga, R.; Raghuvanshi, R. S.; Srivastava, S. Ensuring Product Safety: A Comprehensive Retrospective Study of USFDA Drug Recalls (2019–2023). Journal of Pharmaceutical Innovation 2024, 19. https://doi.org/10.1007/s12247-024-09869-z
21. Behera, H. K.; Joga, R.; Yerram, S.; Karnati, P.; Mergu, T.; Gandhi, K.; M, S.; Nathiya, D.; Singh, R. P.; Srivastava, S.; Kumar, S. Exploring the Regulatory Framework of Psychedelics in the US & Europe. Asian Journal of Psychiatry 2024, 102, 104242. https://doi.org/10.1016/j.ajp.2024.104242
22. Aglave, G.; Yerram, S.; Patnam, J. D.; Ajmal, C. S.; Nizam, V. P. M.; Joga, R.; Raghuvanshi, R. S.; Srivastava, S. Proactive Approaches to cGMP Compliance: Insights and Key Takeaways from USFDA Warning Letters to Pharmaceutical Industries Between 2019 and 2024. Journal of Pharmaceutical Innovation 2024, 19. https://doi.org/10.1007/s12247-024-09857-3
23. Abishek; Muskan; Srivastava, S.; Prasad, P.; Kumar, S. FDA Approval of Zituvio for Type 2 Diabetes. Current Indian Science 2024, 02. https://doi.org/10.2174/012210299x286824240722042737
24. Kirthiga, D.; Joga, R.; Srivastava, S.; Nagpal, K.; Dhamija, I.; Grover, P.; Kumar, S. Regulatory Landscape and Challenges in CAR-T Cell Therapy Development in the US, EU, Japan, and India. European Journal of Pharmaceutics and Biopharmaceutics 2024, 201, 114361. https://doi.org/10.1016/j.ejpb.2024.114361
25. Varpe, P.; Joga, R.; Aglave, G.; Vasu, P.; Yerram, S.; Bellapu, K. K.; Srivastava, S.; Kumar, S. Esterase Responsive Release of Anti-Cancer Agents from Conjugated Lipid Nanocarrier and the Regulatory Considerations. Pharmaceutical Patent Analyst 2024, 13, 31–43. https://doi.org/10.1080/20468954.2024.2347796
26. Arya, D. K.; Deshpande, H.; Kumar, A.; Chidambaram, K.; Pandey, P.; Anjum, S.; Deepak, P.; Kumar, V.; Kumar, S.; Pandey, G.; Srivastava, S.; Rajinikanth, P. S. HER-2 Receptor and αvβ3 Integrin Dual-Ligand Surface-Functionalized Liposome for Metastatic Breast Cancer Therapy. Pharmaceutics 2024, 16. https://doi.org/10.3390/pharmaceutics16091128
27. Bhale, N. A.; Shah, S.; Jahnavi, A. S.; Vishwakarma, A.; Thakur, T. S.; Thomas, S. P.; Srivastava, S.; Dikundwar, A. G. Three Strikingly Different Crystal Habits of Tadalafil: Design, Characterization, Pharmaceutical Performance, and Computational Studies. Molecular Pharmaceutics 2024, 21, 6234–6244. https://doi.org/10.1021/acs.molpharmaceut.4c00601
28. Tandulje, A.; Varpe, P.; Chaugule, P.; Raghuvanshi, R. S.; Srivastava, S. Deciphering the US Regulatory Framework: Comparison Between Oncology Biosimilars and Reference Biologics. Seminars in Oncology 2024, 51, 135–141. https://doi.org/10.1053/j.seminoncol.2024.08.002
29. Sharma, A.; Dey, S.; Naga Sidhartha, N.; Shah, S.; Sapkal, R.; Srivastava, S.; Dikundwar, A. G. Coamorphous Systems of Rebamipide: Selection of Amino Acid Coformers Based on Protein-Ligand Docking, In Vitro Assessment and Study of Interactions by Computational and Multivariate Analysis. International Journal of Pharmaceutics 2024, 667, 124955. https://doi.org/10.1016/j.ijpharm.2024.124955
30. Kanaujiya, S.; Arya, D. K.; Pandey, P.; Anjum, S.; Anjum, M. M.; Ali, D.; Alarifi, S.; Srivastava, S.; Rajinikanth, P. S.; Singh, S.; Pandey, G.; Vijayakumar, M. R.; Sivakumar, S. Resveratrol-Ampicillin Dual-Drug Loaded Polyvinylpyrrolidone/Polyvinyl Alcohol Biomimic Electrospun Nanofiber Enriched with Collagen for Efficient Burn Wound Repair. International Journal of Nanomedicine 2024, 19, 5397–5418. https://doi.org/10.2147/IJN.S464046
31. Famta, P.; Shah, S.; Srinivasarao, D. A.; Sharma, A.; Kumar, R.; Vambhurkar, G.; Pandey, G.; Prasad, S. B.; Shinde, A.; Asthana, A.; Ratna, P. K.; Kumar, B. K.; Arya, D. K.; Rajinikanth, P. S.; Srivastava, S. Simvastatin-Loaded Gelatin-Capped Polycaprolactone Nanoparticles for the Post-Operative Management of Breast Cancer. Journal of Drug Delivery Science and Technology 2024, 101, 106163. https://doi.org/10.1016/j.jddst.2024.106163
32. Negi, M.; Amulya, E.; Phatale, V.; Abraham, N.; Hedaoo, A.; Srinivasarao, D. A.; Srivastava, S. Surface Engineered Nano Architectonics: An Evolving Paradigm for Tackling Alzheimer’s Disease. Life Sciences 2024, 358, 123155. https://doi.org/10.1016/j.lfs.2024.123155
33. Pandey, G.; Kolipaka, T.; Phatale, V.; Khairnar, P.; Abraham, N.; Shah, S.; Famta, P.; Vambhurkar, G.; Srinivasarao, D. A.; Saraf, S.; Srivastava, S. Exploring the Potential of Nano-Biomaterials in Tissue Engineering. Biomaterials in Nanomedicines for Targeted Therapy 2024, 31–54. https://doi.org/10.1007/978-981-97-3925-7_2
34. Phatale, V.; Kolipaka, T.; Khairnar, P.; Pandey, G.; Negi, M.; Saraf, S.; Srivastava, S. Nano-Biomaterial-Assisted Targeted Therapy of Central Nervous System Disorders. Biomaterials in Nanomedicines for Targeted Therapy 2024, 305–328. https://doi.org/10.1007/978-981-97-3925-7_11
35. Khairnar, P.; Phatale, V.; Shukla, S.; Tijani, A. O.; Hedaoo, A.; Strauss, J.; Verana, G.; Vambhurkar, G.; Puri, A.; Srivastava, S. Nanocarrier-Integrated Microneedles: Divulging the Potential of Novel Frontiers for Fostering the Management of Skin Ailments. Molecular Pharmaceutics 2024, 21, 2118–2147. https://doi.org/10.1021/acs.molpharmaceut.4c00144
36. Shinde, A.; Prasad, S. B.; Srinivasarao, D. A.; Shah, S.; Famta, P.; Khairnar, P.; Pandey, G.; Vambhurkar, G.; Hedaoo, A.; Kumar, R.; Srivastava, S. Nano Voyagers: Pioneering a New Frontier in Cancer Treatment with Nanorobots as Drug Transporters. Applied Materials Today 2024, 38, 102162. https://doi.org/10.1016/j.apmt.2024.102162
37. Amulya, E.; Bahuguna, D.; Negi, M.; Phatale, V.; Sikder, A.; Vambhurkar, G.; Katta, C. B.; Dandekar, M. P.; Madan, J.; Srivastava, S. Lipid Engineered Nanomaterials: A Novel Paradigm Shift for Combating Stroke. Applied Materials Today 2024, 38, 102194. https://doi.org/10.1016/j.apmt.2024.102194
38. Nene, S.; Vambhurkar, G.; Tryphena, K. P.; Singh, P. K.; Khatri, D. K.; Srivastava, S. Evaluation of Preclinical Efficacy of Apremilast-Loaded Liquid Crystalline Nanoparticulate Gel in Amelioration of Atopic Dermatitis. Journal of Drug Delivery Science and Technology 2024, 96, 105653. https://doi.org/10.1016/j.jddst.2024.105653
39. Pandey, G.; Phatale, V.; Khairnar, P.; Kolipaka, T.; Shah, S.; Famta, P.; Jain, N.; Srinivasarao, D. A.; Rajinikanth, P. S.; Raghuvanshi, R. S.; Srivastava, S. Supramolecular Self-Assembled Peptide-Engineered Nanofibers: A Propitious Proposition for Cancer Therapy. International Journal of Biological Macromolecules 2024, 256, 128452. https://doi.org/10.1016/j.ijbiomac.2023.128452
40. Pandey, G.; Kolipaka, T.; Srinivasarao, D. A.; Abraham, N.; Tickoo, V.; Khatri, D. K.; Raghuvanshi, R. S.; Srivastava, S. Nanotechnology Invigorated Drug Delivery and Tissue Engineering Strategies for the Management of Diabetic Foot Ulcers: Therapeutic Approaches and Clinical Applications. Journal of Drug Delivery Science and Technology 2024, 96, 105665. https://doi.org/10.1016/j.jddst.2024.105665
41. Kolipaka, T.; Pandey, G.; Abraham, N.; Srinivasarao, D. A.; Raghuvanshi, R. S.; Rajinikanth, P. S.; Tickoo, V.; Srivastava, S. Stimuli-Responsive Polysaccharide-Based Smart Hydrogels for Diabetic Wound Healing: Design Aspects, Preparation Methods and Regulatory Perspectives. Carbohydrate Polymers 2024, 324, 121537. https://doi.org/10.1016/j.carbpol.2023.121537
42. Khairnar, P.; Kolipaka, T.; Pandey, G.; Phatale, V.; Shah, S.; Srinivasarao, D. A.; Saraf, S.; Srivastava, S. Nanosponge-Mediated Oligonucleotide Delivery: A Cutting-Edge Technology towards Cancer Management. Journal of Drug Delivery Science and Technology 2024, 91, 105226. https://doi.org/10.1016/j.jddst.2023.105226
43. Vambhurkar, G.; Famta, P.; Shah, S.; Jain, N.; Srinivasarao, D. A.; Sharma, A.; Shahrukh, S.; Khatri, D. K.; Singh, S. B.; Srivastava, S. Quality by Design Galvanized Development of Resveratrol Loaded PLGA Nanoparticles: In Vitro and Ex Vivo Evaluation for the Non-Invasive Treatment of Metastatic Melanoma. Journal of Drug Delivery Science and Technology 2024, 91, 105252. https://doi.org/10.1016/j.jddst.2023.105252
44. Shah, S.; Famta, P.; Srinivasarao, D. A.; Shahrukh, S.; Jain, N.; Shinde, A.; Prasad, S. B.; Vambhurkar, G.; Pandey, G.; Kumar, R.; Saraf, S.; Srivastava, S. Nanomedicine-RNAi Interface: Architypes in Prostate Cancer Therapeutics. Journal of Drug Delivery Science and Technology 2024, 92, 105349. https://doi.org/10.1016/j.jddst.2024.105349
45. Nooreen, R.; Nene, S.; Vambhurkar, G.; Srivastava, S. Transdermal Delivery and Exploration of Preclinical Anti-Rheumatoid Efficacy of Pirfenidone Embedded Nanoemulgel in Adjuvant-Induced Rat Model. Journal of Drug Delivery Science and Technology 2024, 93, 105428. https://doi.org/10.1016/j.jddst.2024.105428
46. Shah, S.; Famta, P.; Kumar, R.; Sharma, A.; Vambhurkar, G.; Pandey, G.; Singh, G.; Kumar, P.; Mehra, A.; Mourya, A.; Srinivasarao, D. A.; Shinde, A.; Prasad, S. B.; Khatri, D. K.; Madan, J.; Srivastava, S. Quality by Design Fostered Fabrication of Cabazitaxel Loaded pH-Responsive Improved Nanotherapeutics Against Prostate Cancer. Colloids and Surfaces B: Biointerfaces 2024, 234, 113732. https://doi.org/10.1016/j.colsurfb.2023.113732
47. Shahrukh, S.; Jain, N.; Shah, S.; Famta, P.; Vambhurkar, G.; Srinivasarao, D. A.; Sharma, A.; Kumar, R.; Shinde, A.; Prasad, S. B.; Singh, S. B.; Srivastava, S. Quality by Design Enabled Tumor Microenvironment-Responsive Simvastatin-Loaded Liposomes for Prostate Cancer Management. Journal of Drug Delivery Science and Technology 2024, 94, 105474. https://doi.org/10.1016/j.jddst.2024.105474
48. Manchanda, N.; Vishkarma, H.; Goyal, M.; Shah, S.; Famta, P.; Talegaonkar, S.; Srivastava, S. Surface Functionalized Lipid Nanoparticles in Promoting Therapeutic Outcomes: An Insight View of the Dynamic Drug Delivery System. Current Drug Targets 2024, 25, 278–300. https://doi.org/10.2174/0113894501285598240216065627
49. Abraham, N.; Kolipaka, T.; Pandey, G.; Negi, M.; Srinivasarao, D. A.; Srivastava, S. Revolutionizing Pancreatic Islet Organoid Transplants: Improving Engraftment and Exploring Future Frontiers. Life Sciences 2024, 343, 122545. https://doi.org/10.1016/j.lfs.2024.122545
50. Shah, S.; Famta, P.; Vambhurkar, G.; Bagasariya, D.; Kumar, K. C.; Srinivasarao, D. A.; Begum, N.; Sharma, A.; Shahrukh, S.; Jain, N.; Khatri, D. K.; Srivastava, S. Sulfo-Butyl Ether β-Cyclodextrin Inclusion Complexes of Bosutinib: In Silico, In Vitro and In Vivo Evaluation in Attenuating the Fast-Fed Variability. Drug Delivery and Translational Research 2024, 14, 1218–1231. https://doi.org/10.1007/s13346-023-01453-1
51. Hedaoo, A.; Khairnar, P.; Vambhurkar, G.; Srinivasarao, D. A.; Negi, M.; Shinde, A.; Srivastava, S. Unveiling the Potential of Inorganic Nanoarchitecture-Mediated Photothermal Therapy: An Illustration on Melanoma. European Polymer Journal 2024, 216, 113282. https://doi.org/10.1016/j.eurpolymj.2024.113282
52. Chaudhuri, A.; Kumar, D. N.; Srivastava, S. K.; Kumar, D.; Patil, U. K.; Parmar, A. S.; Singh, S.; Agrawal, A. K. Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach. Pharmaceutics 2024, 16. https://doi.org/10.3390/pharmaceutics16070926
53. Pandey, P.; Arya, D. K.; Deepak, P.; Ali, D.; Alarifi, S.; Srivastava, S.; Lavasanifar, A.; Rajinikanth, P. S. αvβ3 Integrin and Folate-Targeted pH-Sensitive Liposomes with Dual Ligand Modification for Metastatic Breast Cancer Treatment. Bioengineering 2024, 11. https://doi.org/10.3390/bioengineering11080800
54. Famta, P.; Shah, S.; Sharma, A.; Pandey, G.; Vambhurkar, G.; Srinivasarao, D. A.; Asthana, A.; Kumar, B. K.; Srivastava, S. Exploration of Multi-Layered Nanofiber Adjuvant Implants of Doxorubicin and Resveratrol to Prevent Post-Surgery Tumor Recurrence and Invasion. Journal of Drug Delivery Science and Technology 2024, 99, 105977. https://doi.org/10.1016/j.jddst.2024.105977
55. Singh, G.; Sikder, A.; Singh, S. B.; Srivastava, S.; Khatri, D. K. Drug Delivery Strategies in Parkinson’s Disease. Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities 2024, 305–324. https://doi.org/10.1007/978-981-99-6807-7_13
56. Mourya, A.; Famta, P.; Shah, S.; Srinivasarao, D. A.; Sharma, A.; Vambhurkar, G.; Bojja, B.; Arya, S.; Devanagan, P.; Prasad, S. B.; Shinde, A.; Singh, G.; Khatri, D. K.; Srivastava, S.; Madan, J. Raloxifene Loaded D-α-Tocopherol Polyethylene Glycol 1000 Succinate Stabilized Poly(ε-Caprolactone) Nanoparticles Augmented Drug Delivery and Apoptosis in Breast Cancer Cells. Journal of Drug Delivery Science and Technology 2024, 92, 105399. https://doi.org/10.1016/j.jddst.2024.105399
57. Sikder, A.; Bagasariya, D.; Shah, S.; Famta, P.; Kashikar, R.; Kotha, A. K.; Johnson, K. R.; Archer, B. P.; Chougule, M. B.; Singh, S. B.; Srivastava, S. Polymers in Advanced Drug and Gene Delivery. Polymers in Pharmaceutical and Biomedical Applications: Fundamentals, Selection and Preparation 2024, 291–332. https://doi.org/10.1016/B978-0-323-95496-9.00008-9
58. Palepu, M. S. K.; Bhalerao, H. A.; Sonti, R.; Dandekar, M. P. Faecalibacterium prausnitzii, FOS and GOS Loaded Synbiotic Reverses Treatment-Resistant Depression in Rats: Restoration of Gut-Brain Crosstalk. European Journal of Pharmacology 2024, 983, 176960. https://doi.org/10.1016/j.ejphar.2024.176960
59. Shekh, S.; Dhannura, S.; Dhurjad, P.; Ravali, C.; Spoorti, M. M.; Kakkat, S.; Vijayasarathy, M.; Sonti, R.; Gowd, K. H. Structure-Aided Function Assignment to the Transcriptomic Conopeptide Am931. Toxicon 2024, 250, 108087. https://doi.org/10.1016/j.toxicon.2024.108087
60. Dhannura, S.; Shekh, S.; Dhurjad, P.; Dolle, A.; Kakkat, S.; Vishwajyoth; Vijayasarathy, M.; Sonti, R.; Gowd, K. H. Redox-Active Conopeptide Li520 Has Evolved to Catalyze Oxidative Folding of Conotoxins. ACS Omega 2024, 9, 36. https://doi.org/10.1021/acsomega.4c01028
61. Reddy, G. N.; Jogvanshi, A.; Reddy, D. S.; Chenkual, L.; Sonti, R. DoE-Assisted HPLC Method Development and Validation of Enzalutamide and Repaglinide in Rat Plasma. Bioanalysis 2024, 8, 1. https://doi.org/10.1080/17576180.2024.2383070
62. Dannarm, S. R.; Kalan, P.; Ganta, B.; Reddy, G. N.; Sonti, R. Study on Hydrolytic, Oxidative and Photolytic Degradation Behaviour of Anticancer Drug Sonidegib: Characterization of the Products by UHPLC-Q-TOF-MS/MS, 2D NMR and In Silico Toxicity Assessment. Journal of Environmental Chemical Engineering 2024, 12, 114111. https://doi.org/10.1016/j.jece.2024.114111
63. Sen, S.; Ganta, B.; Rachel, V. N.; Gogikar, S. K.; Singh, V.; Sonti, R.; Dikundwar, A. G. Mapping Advantages and Challenges in Analytical Development for Fixed Dose Combination Products: A Review. Journal of Pharmaceutical Sciences 2024, 113, 2028. https://doi.org/10.1016/j.xphs.2024.04.025
64. Yadav, R.; Bhawale, R.; Srivastava, V.; Pardhi, E.; Bhalerao, H. A.; Sonti, R.; Mehra, N. K. Innovative Nanoparticulate Strategies in Colon Cancer Treatment: A Paradigm Shift. AAPS PharmSciTech 2024, 25, 52. https://doi.org/10.1016/j.xphs.2024.04.025
65. Palepu, M. S. K.; Gajula, S. N. R.; Malleshwari, K.; Sonti, R.; Dandekar, M. P. SCFAs Supplementation Rescues Anxiety- and Depression-Like Phenotypes Generated by Fecal Engraftment of Treatment-Resistant Depression Rats. ACS Chemical Neuroscience 2024, 15, 1010. https://doi.org/10.1021/acschemneuro.3c00727
66. Paladini, J.; Maier, A.; Habazettl, J. M.; Hertel, I.; Sonti, R.; Grzesiek, S. The Molecular Basis of Abelson Kinase Regulation by Its αI-Helix. eLife 2024. https://doi.org/10.1101/2023.10.04.560671
67. Dannarm, R. S.; Dharipally, H.; Reddy, G. N.; Ali, N.; Sonti, R. Study on the Hydrolytic Degradation Behaviour of Bictegravir by LC-PDA-Q/TOF-MS/MS NMR and In Silico Toxicity Assessment. Journal of Pharmaceutical and Biomedical Analysis 2024, 239, 115909. https://doi.org/10.1016/j.jpba.2023.115909
68. Mukhopadhyay, N.; Ahmed, R.; Mishra, K.; Sandbhor, R.; Sharma, R. J.; Kaki, V. R. A Validated, Precise TLC-Densitometry Method for Simultaneous Quantification of Mahanimbine and Koenimbine in Marketed Herbal Formulations. Future Journal of Pharmaceutical Sciences 2024, 10 (1), 23.
69. Makhal, P. N.; Dayare, L. N.; Chilvery, S.; Devi, P.; Shaikh, A. S.; Sharma, A.; Negi, A.; Godugu, C.; Kaki, V. R. Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel N-Substituted Piperazine-Tethered Thiophene-3-Carboxamide Selenides as Potent Antiproliferative Agents. Bioorganic Chemistry 2024, 151, 107677.
70. Arora, S.; Thakur, S.; Kaki, V. R.; Kumar, R. Design and Efficient Synthesis of New 4-Amino-Substituted 2-(4-Bromobenzyl)-5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines of Anticancer Interest and Their In Silico Study. Synthesis 2024, 10.1055/a-2367-1675. https://doi.org/10.1055/a-2367-1675
71. Mukhopadhyay, N.; Mishra, K.; Ahmed, R.; Sandbhor, R.; Sharma, R. J.; Kaki, V. R. Determination of Mahanimbine from Murraya koenigii, Collected from Different Geographical Regions of India, by TLC-Densitometry. Journal of Analytical Chemistry 2024, 79 (8), 1121–1131.
72. Katta, C. B.; Bahuguna, D.; Veerabomma, H.; Gollapalli, S.; Shaikh, A. S.; Bhale, N. A.; Dikundwar, A. G.; Kaki, V. R.; Singh, P. K.; Madan, J. Naringenin-Zinc Oxide Nanocomposites Amalgamated Polymeric Gel Augmented Drug Delivery and Attenuated Experimental Cutaneous Candidiasis in Balb/c Mice: In Vitro and In Vivo Studies. AAPS PharmSciTech 2024, 25 (5), 130.
73. Rahman, Z.; Shaikh, A. S.; Kaki, V. R.; Dandekar, M. P. Oxyberberine Protects Middle Cerebral Artery Occlusion Triggered Cerebral Injury Through TLR4/NLRP3 Pathway in Rats. Journal of Chemical Neuroanatomy 2024, 136, 102393.
74. Makhal, P. N.; Shaikh, A. S.; Dayare, L. N.; Kaki, V. R. Research Philosophy, Ethics, and Environmental Aspects. Principles of Research Methodology and Ethics in Pharmaceutical Sciences 2024, 214–236. (Book Chapter)